Randomized, Double-Blind, Multi-Center, Parallel-Group Comparison of the Efficacy and Safety of the C213 (Zolmitriptan Microneedle System) to Placebo for the Acute Treatment of Cluster Headaches
Latest Information Update: 16 Jun 2022
At a glance
- Drugs Zolmitriptan (Primary)
- Indications Cluster headache
- Focus Therapeutic Use
- Acronyms ATAC
- Sponsors Zosano Pharma
Most Recent Events
- 12 Jun 2022 According to 64th Annual Scientific Meeting of the American Headache Society, most clinical trial sites became active in 2020, which resulted in several sites being closed and made enrollment very difficult, and thus the trial was stopped early.
- 12 Jun 2022 Results presented at the 64th Annual Scientific Meeting of the American Headache Society
- 12 Jun 2022 Status changed to discontinued , according to Results presented at the 64th Annual Scientific Meeting of the American Headache Society